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Abstract
In the postgenomic era, a new strategy for chemical dereplication of polyketide anti-infective
drugs requires novel genomics and chromatographic strategies. An endosymbiotic fungal
strain CLB38 was isolated from the root tissue of Combretum latifolium Blume (Combreta-
ceae) which was collected from the Western Ghats of India. The isolate CLB38 was then
identified as Emericella variecolor by its characteristic stellate ascospores culture morphol-
ogy and molecular analysis of ITS nuclear rDNA and intervening 5.8S rRNA gene sequence.
ITS2 RNA secondary structure modeling clearly distinguished fungal endosymbiont E. varie-
color CLB38 with other lifestyles in the same monophyletic clade. Ethyl acetate fraction of
CLB38 explored a broad spectrum of antimicrobial activity against multidrug resistant patho-
gens. Biosynthetic PKS type-I gene and chromatographic approach afford two polyketide
antimicrobial compounds which identified as evariquinone and isoindolones derivative
emerimidine A. MIC of purified compounds against test microorganisms ranged between
3.12 μg/ml and 12.5 μg/ml. This research highlights the utility of E. variecolor CLB38 as an
anticipate source for anti-infective polyketide metabolites evariquinone and emerimidine A
to combat multidrug resistant microorganisms. Here we demonstrates a chemogenomics
strategy via the feasibility of PKS type-I gene and chromatographic approach as a proficient
method for the rapid prediction and discovery of new polyketides compounds from fungal
endosymbionts.
Introduction
Novel antimicrobial drugs derived from fungal endosymbionts with the unique and targeted
mode of action are fundamental to fight against multidrug-resistant microorganisms[1].
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Despite the current focus on synthetic chemicals, natural products assist as a continuing
source in search of new antimicrobial drugs, retaining an immense impact on modern medi-
cine [2]. Endosymbiotic fungi are an eclectic group of microbes having the power to chemi-
cally colligate the bridge between microbes and medicinal plants due to their relatively high
metabolic versatility [3].They securely establish endophyte–endophyte and plant-endophyte
interactions, which play a vital role in the biosynthesis of anti-infective metabolites [4]. They
are highly considered as unexploited drug sources capable of producing novel anti-infective
metabolites [5].
Biodiscovery of natural drugs and development are resource and time consuming processes
[6]. Application of chemogenomics strategy may provide selective information to predict the
nature of antimicrobial compounds during the bioprospecting of endosymbiotic fungi for
novel metabolites. Furthermore, microbial genome mining revealed the presence of numerous
secondary metabolites gene clusters, displaying a discrepancy between the numbers of putative
genes involved in secondary metabolism [7,8]. Advanced approaches in searching for rapid
identification of polyketide metabolites from fungal endosymbionts require novel genomics
and chemical investigation. Polyketides constitute a diverse group of secondary metabolites
found across bacteria, fungi, plants and some marine microorganisms which play an im-
portant role in drug discovery from natural resources [9]. They governed by multi-domain
enzymes which catalyze iterative events to frame a polyketide molecule [10]. Several antimicro-
bial drugs in the market are of polyketide origin including antibiotics tetracycline and erythro-
mycin, anticholesterol drug lovastatin, anticancer drug epothilone B and immunosuppressant
rapamycin [11].
The genus Emericella was first described by Berkeley [12] (1857) with Emericella variecolor
(anamorph: Aspergillus stellatus syn. A. variecolor) [13]. Emericella is a genus containing spe-
cies of considerable interest because of its well elucidated genetics of E. nidulans [14] and due
to some species which reported to produce penicillin [15]. Member of the genus Emericella is
an ecologically versatile and industrially important group of fungi. It is well known to produce
diverse bioactive compounds like cytotoxic sesterterpenes [16] stromemycin [17], asperthecin,
shamixanthones, sterigmatocystin, andebenin A, B, C as well as xanthones with antimicrobial,
immune stimulant and calmodulin inhibition activities to mention in few [18,19,20]. In the
present research, Combretum latifolium Blume was selected for the isolation of E. variecolor.
C. latifolium Blume is a climbing shrub known as Man daeng or Uat chueak which has
great medicinal values [21]. Stem and bark of this shrub were used as insecticides [22], where
as leaf juice is used to cure dysentery, pneumonia and goitar [23]. The major components pres-
ent in the volatile oil of C. latifolium Blume were hexahydrofarnesyl acetone, isophytol, pal-
mitic acid, neophytadiene and n-nonacosane [24]. Therefore, the present study was carried
out to employ genomic and metabolomic strategy as a rapid screening mini tool for detecting
PKS genes and its antimicrobial metabolites to combat multi-drug resistant pathogens. Here
we discuss the merits of this genomic and metabolomic approach for the rapid detection of
PKS-type I genes which facilities biodiscovery of polyketide antimicrobial compounds.
Materials and methods
Study site characteristics and selection of plant
C. latifolium Blume was collected from Pushpagiri Sanctuary (12˚350N 75˚400E, elevation 1748
m) located in the Western Ghats of Coorg, Karnataka which is covered with evergreen forests
and shoal grassland habitat. The imposing Kumaraparvata peak forms the core of this Sanctu-
ary with dense evergreen forests. The Western Ghats are the mountain ranges that runs almost
parallel to the Western coast of Indian peninsula located entirely in India. It is considered as
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one of the eight ‘hottest hotspots’ of biological diversity exits in the world [25]. No specific per-
missions were required for this location for plant sample collection and the field studies did
not involve any endangered or protected species.
Collection of samples
Healthy and asymptomatic leaf, stem and root tissue samples of C. latifolium Blume was carefully
collected. In order to secure the endosymbiotic nature of the isolate, blunt ends of the stem and
root tissues were sealed with wax. All tissue samples were carried in an icebox and stored at 4˚C.
All tissue samples were used for the isolation of fungal endosymbionts within 24 h of collection.
Isolation of endosymbiotic fungi
Isolation of endosymbiotic fungi and its secondary metabolites were carried out as described in
detail from our previous studies with some modifications [26]. Surface sterilization: Each sam-
ple tissue was washed under running tap water for 15 min and dried at room temperature. All
samples were washed with distilled water before processing and slight visibly damaged material
was discarded. To remove the epiphytic microorganisms, sample tissues were rinsed with 70%
ethanol for 2 min, surface sterilized by sodium hypochlorite (4%) for 5 min and again rinsed
with 70% ethanol for 30 s. Sample tissues were then washed with sterile double distilled water
and kept for surface drying in sterile condition. The tissue samples were cut into small segments
(1 cm) and placed on water agar plates (distilled water, 1.5% agar) amended with chlorampheni-
col (250 ppm), then incubated at 28±2˚C for 7 days to till growth initiated [2]. To confirm the
success of surface disinfection process, aliquots of the sterile double distilled water from the
final rinse were inoculated on the isolation medium plates. The hyphal tips which emerged
from the sample tissues were picked and maintained on PDA plates for further studies.
Fermentation and extraction of antimicrobial metabolite
E. variecolor CLB38 was cultured in 1 L Erlenmeyer flask containing 250 ml of potato dextrose
broth (PDB). The culture was incubated for 30 days at 28˚C under static conditions. Culture
broth was then filtered to separate mycelium and culture broth. The filtered culture broth was
blended thoroughly and centrifuged at 4000 r/min for 10 min in order to obtain pure culture
broth. The liquid supernatant was then extracted three times with an equal volume of ethyl
acetate and evaporated to dryness under reduced pressure at 45˚C using rotary flash evapora-
tor [27].
Antimicrobial activity
Determination of antimicrobial susceptibility test was carried out by disc diffusion method.
Sterile discs (6 mm) impregnated with 20 μl (100 μg/disc) of ethyl acetate extract obtained
from the culture broth of E. variecolor CLB38 were dried in laminar air flow and placed on the
surface of the medium which seeded with test human pathogens in Petri plates. A disc as nega-
tive control with only 20 μl of ethyl acetate was also placed for each test pathogen and Genta-
micin as positive control. The plates were then incubated at 37±2˚C and 28±2˚C (for test
bacteria and fungi respectively). The diameter of the zone of inhibition was recorded [28].
Statistical analyses
Statistical analysis of results was performed using IBM SPSS version 20. Analysis of variance
(one way ANOVA) at value p<0.001 followed by Tukey’s Post Hoc test with p<0.05 was used
to determine the significant difference between the results obtained in each experiment.
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Isolation of genomic DNA, PCR amplification and DNA sequencing
E. variecolorCLB38was cultured in potato dextrose broth for 7 days at 30˚C and the mycelium
was harvested by vacuum filtration. The chilled mycelia were ground with a pestle and mortar
under liquid nitrogen. Then, the grinded mycelia were transferred into a micro centrifuge tube
with 1 ml of 2×CTAB extraction buffer and incubated at 65˚C for 30 min with gentle swirling.
After centrifugation at 10000 rpm for 10 min, aqueous phase of the mixture containing total
DNA was extracted with an equal volume phenol:chloroform:isoamyl alcohol (25:38:1). Resid-
ual phenol was removed by the addition of chloroform:isoamyl alcohol (38:1) twice. Two vol-
ume ethanol and 0.1 volume 3 M sodium acetate were added to the aqueous phase of DNA to
precipitate and incubated at -20˚C over-night. The DNA pellet was then washed with 70% etha-
nol twice and suspended in 15 μl of TE buffer [29]. PCR amplification was carried according to
the protocol of Bhagat et al. (2012) [30] using ITS1 (50 TCCGTAGGTGAACCTGCGG30) and
ITS4 (50 TCCTCCGCTTATTGATATGC30) set of universal primers [31]. DNA sequencing was
performed using an ABI 3730 sequencer (Applied Biosystems, United States).
Phylogenetic affiliation
Internal transcribed spacer (ITS) sequence data from strain E. variecolor CLB38was annotated
using Geneious 6.1.6 (2013), Biomatters, Auckland, New Zealand) software and submitted to
National Centre for Biotechnology Information(NCBI) GenBank. ITS rDNA sequences with
maximum identity to that of strain CLB38were retrieved from NCBI nucleotide database
using Basic Local Alignment Search Tool (BLAST) search. ITS sequences were filter-searched
and closest resembles sequences were retrieved for phylogenetic analysis. Multiple sequence
alignments were performed using CLUSTALW software utilizing default settings and dendro-
gram was generated by MEGA 4.0 with a bootstrap consensus of 1000 replicates [32].
RNA secondary structure analysis
The ITS2 sequences of strain CLB38 and its closest matches in the phylogenetic clade were
selected to predict the ITS2 RNA secondary structure using mfold server with a preset temper-
ature of 37˚C and following conditions: ionic conditions, maximum asymmetry of bulge loop
at 30; 1 M NaCl with no divalent ions; maximum number of nucleotides in a bulge or loop lim-
ited to 30; percentage sub-optimality number 5; upper bound on number of computed folding
50 and the structure selected from dissimilar output files are with the high negative free energy
if several similar structures obtained [26,33].
Occurrence of biosynthetic polyketide synthase (PKS) genes
Biosynthetic gene clusters encoding PKS keto synthase domain was detected using three sets of
degenerate primers: LC1 and LC2c, LC3 and LC5c [34], KS3 and KS4c [35], which are keto-
synthase domain degenerate primers were used to amplify the PKS genes of E. variecolorCLB38.
PCR reactions (50 μl) contained 4 μl DNA template, 5 μl 10×PCR buffer, 4 μl 2.5 mM of each
dNTPs, 3 μl of each primer, 1 μl of 5 U/μl rTaq DNA polymerase and 30 μl deionized water.
Thermal cycling program: 5 min at 94˚C; 34 cycles of 1 min at 94˚C, 1.5 min at 55˚C, 3 min at
72˚C and 10 min at 72˚C.
Structural and functional analyses of PKS gene
The PKS gene secondary functional and structure prediction was carried out using Iterative
Threading Assembly Refinement (I-TASSER) online bioinformatics software [36]. This algo-
rithm modeled based on LOMETS multiple-threading alignment and TASSER iterative
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simulation [37]. The translated protein sequence was derived from PKS nucleotide sequence
using ORF finder and searched for related proteins using BLASTP algorithm [38]. PKS
enzyme active sites and its sequence were detected using Swiss-pdb viewer and online-web
server Scan prosite tool. Quality assessment of the predicted protein 3D model was estimated
using based on the Z-Score and RMSD values. Predicted protein 3D model quality was
assessed using Q mean score [39]. The C-score (confidence score), TM-score (template model-
ing score) and ligand binding sites were determined for the binding bioactive molecule [40].
Thin layer chromatography–bioautography
Antimicrobial activity of secondary metabolites fromstrainCLB38 was determined by analytical
thin-layer chromatography (TLC) bioautography method [41]. Ten microlitres of ethyl acetate
fraction of E. variecolorCLB38was spotted on TLC silica gel plates (TLC, Alugram SIL G/UV254;
Machereye-Nagel, Duren, Germany) in an optimized solvent system of petroleum ether/ethyl
acetate (1:2). The developed TLC sheets were then observed under ultraviolet (UV) light (254
nm). TLC plates were then air dried in sterile condition for the complete removal of solvent
traces and ultraviolet radiation sterilized for 30 min. Later, the developed TLC plates were cased
in sterile Petri plates overlaid with Brain heart infusion medium containing 0.65% soft agar
incorporated with 1 mgml-1 concentration of 2,3,5-triphenyl tetrazolium chloride (TTC; Sigma-
Aldrich) inoculated with 1% standardized microbial inocula. After 2 h of diffusion at 8˚C, Petri
plates were incubated for 38 h at 37˚C. The zone of inhibition on the active spot was recorded.
Purification of antimicrobial compounds
Antimicrobial compounds from ethyl acetate extract of CLB38 were purified inthe two-step
purification process. First, the concentrated extract was fractionated using silica gel (60–200
mesh; HiMedia, Mumbai, India) column chromatography (50 cm×1 cm) eluted successively
with hexane/ethyl acetate(v/v, 100:0, 95:5, 90:10, 80:20, 70:30, 60:40, 50:50, 40:60, 30:70, 20:80,
10:90, 5:95 and 0:100, respectively) to afford 13(F1~F13) eluted fractions. In order to pool
similar eluted bioactive fractions, 10 μl of eluted fractions were spotted on TLC silica gel
plates separately and observed for similar band pattern under UV light (254 nm). Fractions
F3~F5and F8~F10, these two groups of fractions showed similar band patterns differ from
each group and exhibited strong antimicrobial activity during TLC bioautography. Therefore,
active fractions F3~F5 (Group A) and F8~F10 (Group B) were separately pooled together and
re-chromatographed over silica gel column (60–200 mesh; Hi Media, Mumbai, India) eluting
in mobile phase methanol/ethyl acetate in order to obtain high purity of the compounds (v/v,
20:80, 40:60, 60:40 and 80:20, respectively). From the secondary step of purification, group A
and group B eluted fractions exhibited strong antimicrobial activity against MRSA, therefore
these active fractions were combined separately and evaporated to dryness.
Structure elucidation of antimicrobial compounds
Electrospray ionization time-of-flight mass spectrometry (ESI-TOF-MS) was carried out using
an LCT liquid chromatogram–mass spectrometer (Micromass Q-Tof). Optical rotation was
measured on a JASCO P-1020 polarimeter. NMR spectral analyses were recorded in BRU-
KER-AV400 spectrometer using CDCl3 solvent.
Minimum inhibitory concentration (MIC) of antimicrobial compounds
MIC of the purified compounds was determined by micro broth dilution assay in 96-well plate
method[42]. The purified compound was tested in two-fold dilution of concentration range
Chemogenomics driven discovery of polyketide anti-infective drugs from Emericella variecolor CLB38
PLOS ONE | DOI:10.1371/journal.pone.0172848 February 28, 2017 5 / 18
200–0.3906 μg/ml. 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT;
Sigma-Aldrich, Bengaluru, India) and 2,3,5-Triphenyltetrazolium chloride (TTC) were added
to each well for test fungi and bacteria respectively, as microbial growth indicators. Gentami-
cin and nystatin were used as positive controls, whereas medium broth alone served as nega-
tive control/sterility control. The lowest concentration of the purified compound with no
visible growth as indicated by the growth indicators was determined as MIC.
Results and discussion
Isolation of endosymbiotic fungi
Fungal endosymbionts with the unique and targeted mode of action can impact plant biology
through the biosynthesis of diverse chemical entities and modulating gene expression of the
host [43]. In the present study, a fungal endosymbiont E. variecolorCLB38was isolated from
the asymptomatic root of C. latifolium Blume. Growth of bacterial endosymbionts was effec-
tively inhibited by amending the medium with chloramphenicol (250 ppm). In addition, isola-
tion medium plates spread with a final rinse of water do not exhibit any microbial growth even
after 10 days of incubation at 28˚C. This suggests that the surface sterilization procedure was
effective in killing all epiphytic microbes. Thus, the subsequent isolate can be considered as
true endosymbiotic fungus [44]. Colony morphology on potato dextrose agar after 7 days of
incubation at 28˚C initially light green to yellow, later turns to yellow around the corner, margin
regular with smooth surface, produced stellate ascospores. The isolated endosymbiotic fungus
was then identified as Emericella sp. on the basis of morphological and microscopic characteris-
tics (Fig 1). However, molecular analysis of ITS region of rDNA and intervening 5.8S rRNA
gene sequence analysis was carried out in order to identify the strain at species level.
Phylogenetic affiliation
Molecular identification of the isolate CLB38 was carried out by ITS region of rDNA and inter-
vening 5.8S rRNA gene sequence analysis (Fig 2). PCR amplified ITS region of rDNA was
sequenced and aligned with different Emericella spp. retrieved from NCBI using BLAST search.
ITS sequence alignment retrieved from NCBI database showed several closely resembled
sequences. Corresponding neighbor joining (NJ) tree depict clearly that, strain CLB38 fell into
the group of Emericella variecolor with strong support (Fig 3). BLAST hits and NJ dendrogram
generated indicating that isolate CLB38 was more homologous to Emericella variecolor isolate
NRRL 1858 (GenBank accession no. EF653826.1). There are several previously phylogenetically
unstudied endosymbiotic fungi exits [45]; however, morphological identification of fungi has
long been usage which is beyond doubt and great significance [46]. ITS rDNA and intervening
5.8S rRNA gene sequence profiling is a cost-effective tool which enables to identify the complex
microbial plethora at the species level in exceptional depth [47]. Finally, combined with mor-
phological and phylogenetic data, strain CLB38 was defined as Emericella variecolor. The ITS
sequence data of this fungus is deposited in GenBank under the accession no. KU577138.
Occurrence of biosynthetic PKS genes
In addition, the presence of biosynthetic PKS genes encoding keto synthase (KS) domain of strain
CLB38 was detected using LC1-LC2c, LC3-LC5c and KS3-KS4c degenerate primers which are
specifically for non-reduced, partially reduced and highly reduced KS domains of endosymbiotic
fungal polyketide compounds. Genomic DNA of E. variecolor CLB38 amplified with LC3-LC5c
pairs of degenerate primers. Endosymbiotic fungi have been screened genetically to detect the
presence of PKS genes as indicators of bioactivity. This encodes an uncharacterized functional
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enzyme which might suggest a new function for antimicrobial polyketide production [48].
The PKS gene sequence data of this fungus is deposited in GenBank under the accession no.
KU577139. Lin et al. (2010) [49] reported some fungal endophytes amplified with LC1-LC2c pair
of degenerate primers. Endophytic fungal type I polyketides compounds are biosynthesized by
multi-domain enzymes, which employ an iterative strategy to build polyketide molecules [10].
Structural and functional analyses of PKS gene
Functional annotation and comparative 3D structure modeling and tertiary structure analysis
of ketosynthase domain of PKS gene were generated ‘in silico’ (Fig 4).The predicted structure of
the PKS protein sequence revealed its primary structure oligo state as homo-dimer. The model
resulted conformational stability and likelihood to the template, qualitative values for structural
assessment in terms C-score 6.21, TM–score 0.94±0.05 and RMSD score 2.3±1.8Å. It assists
pre-selection or endosymbiotic microbial strain prioritization capable of producing new antimi-
crobial metabolites. ProFunc and active site prediction tools were used to predict the function
of modeled protein. I-TASSER server results predict accurate structure and function base on
state-of-the-art algorithm [36]. This facilitates PKS gene screening approach as the best method
to screen and ascertain the genetic biosynthetic potential for fungal endophytes from the per-
spective of natural product discovery and might serve as indicators of bioactivities [34,49].
RNA secondary structure analysis
ITS2 RNA secondary structure prediction of E. variecolor CLB38 with its close phylogeny
clade member of E. variecolor NRRL 1858 (EF652426) was generated in silico. The ITS2
sequence was used as markers in molecular systematics and phylogenetic reconstruction [26].
The generated RNA secondary structures showed structural differences between these two
Fig 1. (a) Colony morphology of endosymbiotic Emericella variecolor CLB38 on potato dextrose agar, (b) microscopic stellate ascospores at 40X
magnification.
doi:10.1371/journal.pone.0172848.g001
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strains.ITS2 RNA secondary structure of E. variecolor NRRL 1858 displays branched unpaired
region where as isolate CLB38 appeared linear in structure and also variations in stem/loop
transition were observed (Fig 5). ITS2 RNA structures are sensible to single base changes
Fig 2. PCR amplification of rDNA from Emericella variecolor CLB38 using ITS1 and ITS4 universal
primers. Lane: M—100 bp DNA ladder; CLB38 –~575 bp amplicon representing ITS region of rDNA; C–
control.
doi:10.1371/journal.pone.0172848.g002
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which in turn can affect hydrogen base pairing in stem and loop secondary structures [50].
A non-conserved mismatches might altered base-pairing and stem to loop transitions by
counterparts [42,51]. Studies have reported many fungi might express different life-styles in
response to environmental factors or host genotype [52]. These findings might suggest that E.
variecolor CLB38 differ by dangling region and unpaired variation of E. variecolor NRRL 1858
due to their endosymbiotic nature. Therefore, CLB38 is a unique potential source of novel
antimicrobial drugs to combat multi drug resistant pathogens.
Antimicrobial activity
Ethyl acetate extract of culture broth of E. variecolorCLB38was analyzed by disc diffusion assay
to assess anti-infective potential. Strain CLB38 exhibited strong antimicrobial activity, whereas
significant activity was observed against Bacillus subtilis (26.00±0.00 mm), Staphylococcus
aureus (24.00±0.00 mm), Escherichia coli (23.33±0.33 mm) Methicillin resistant Staphylococcus
aureus (22.33±0.33) and antifungal activity against Candida albicans (19.00±0.00mm). The
capacity of E. variecolor CLB38 to inhibit both bacterial and fungal pathogens implies that sec-
ondary metabolites produced have a broad range of antimicrobial activity. Diameters of zone
of inhibition against test pathogens are given in Table 1. The results obtained were validated
with standard antibiotics, gentamicin and nystatin for antibacterial and antifungal activity,
respectively. This endosymbiont might involve in defending the host against invading various
pathogens and this could have extended the ability of endosymbiont to biosynthesize some
chemical entities [2]. E. variecolor has been reported to exhibit bioactivities invitro [16,17].
Endophytic fungi inhabiting medicinal plants from Western Ghats of India were recorded to
show antimicrobial and cytotoxic activities [53,54]. Similarly, endophytic actinomycetes and
endophytic fungi inhabiting C. latifolium Blume which collected from the Western Ghats of
India, were also reported to show antimicrobial activity in our previous studies [55,56]. Hence,
this study expands our knowledge of potent hidden endosymbionts from underexplored area
are a potential source of novel antimicrobial agents.
Thin layer chromatography-bioautography
TLC metabolic profiling of ethyl acetate extract of CLB38 displayed the presence of two intense
bands under 254 nm and 365 nm. Band at Rf 0.58 and Rf 0.46 appeared yellow and blue in
color, respectively (Fig 6). These intense bands might be due to the increased production of
Fig 3. Phylogenetic tree derived from NJ analysis showing the evolutionary relationship of Emericella
variecolor CLB38 with its closest BLAST hits. Bootstrap values (1000 replications) based on multiple
sequence alignment using the MEGA-5 software. Asterisk indicates the isolate obtained in this study.
doi:10.1371/journal.pone.0172848.g003
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bioactive metabolites. During TLC-bioautography assay, these two bands exhibited clear zone
of inhibition where the medium was pre-inoculated with MRSA and TTC agent. This confirms
antimicrobial compounds present in the ethyl acetate fraction which was active against MRSA.
Antimicrobial compounds detection by TLC-bioautography method is one of the economical,
simplest and reproducible method for biodiscovery from nature products [57,58].Antimicro-
bial TLC bioautography was used as bio-assay to monitor antimicrobial compound purifica-
tion process by column and thin layer chromatography. Biodiscovery of antimicrobial
producing fungal endosymbionts associated with C. latifolium Blume is valuable for industrial
interest and for basic research.
Purification of antimicrobial compounds
Purification of antimicrobial compounds was carried out in two step purification process.
Thirteen fractions (F1~F13) derived from silica gel column chromatography were analyzed by
TLC–bioautography for antimicrobial potential. Fractions F3~F5and F8~F10 showed similar
TLC patterns differ from each group which are active against MRSA. Since MRSA is a multi-
drug-resistant pathogen, we used as an indicator organism to assess the anti-infective potential
of these compounds. Thus, these two groups of fractions were combined and re-chromato-
graphed over silica gel column separately in order to obtain highly purified compounds.
Further, from the secondary step of purification, the eluted fractions from each group were
combined, evaporated to dryness which furnished two compounds as yellow crystals (group A
fractions; compound (1) and colorless crystals (group B fractions; compound 2).
Fig 4. (a) 3D modeled structure based on the deduced amino acid sequence of E. variecolor CLB38 PKS gene using I-TASSER model, (b) Predicted ligand-
binding site of E. variecolor CLB38 PKS protein.
doi:10.1371/journal.pone.0172848.g004
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Fig 5. ITS2 RNA secondary structure of (a) Emericella variecolor isolate NRRL 1858 and (b) Emericella variecolor CLB38.
doi:10.1371/journal.pone.0172848.g005
Table 1. Determination of antimicrobial activity of ethyl acetate fraction of endosymbiotic Emericella variecolor CLB38 (100 μg/disc) against test
microorganisms.
Test Pathogens Ethyl acetate extract 100 μg/disc Gentamicin 10 μg/disc Nystatin 100 μg/disc
Aspergillus fumigatus (MTCC 1811) 17.00±0.57f ND 20.66±0.57f
Bacillus subtilis (MTCC 121) 26.00±0.00a 31.00±0.00b ND
Candida albicans (MTCC 183) 19.00±0.00e ND 21.00±0.57f
Escherichia coli (MTCC 7410) 23.33±0.33bc 29.33±0.33bc ND
Klebsiella pneumonia (MTCC 7407) 19.00±0.00e 27.00±0.00de ND
Listeria monocytogenes (MTCC 839) 23.33±0.33c 28.00±0.57cd ND
Methicillin resistant Staphylococcus aureus (ATCC 33915) 22.33±0.33cd 28.66±0.33cd ND
Pseudomonas aeruginosa (MTCC 7903) 22.33±0.33bcd 25.33±0.33e ND
Salmonella typhi (MTCC 733) 21.00±0.00d 28.66±0.33cd ND
Staphylococcus aureus (MTCC 7443) 24.00±0.00b 33.00±0.00a ND
Note: Values represents diameter of zone of inhibition in mm. Data represented are means from three replicates ± SE and those representing similar
superscripts within columns are significantly different (ONE WAY ANOVA and Tukey’s HSD at p<0.05). ND–not determined
doi:10.1371/journal.pone.0172848.t001
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Structure elucidation of antimicrobial compounds
Evariquinone (1) was isolated as pale yellow amorphous powder. Its molecular formula was
deduced to be C16H12O6 by m/z 300.0458 (Fig 7). 1H NMR chemical shifts (DMSOd6, 400
MHz, δ ppm): δ 2.421 (3H, s,CH3), 3.97 (3H, s, OCH3), 6.951 (1H, s, Ar-H), 7.212 (1H, d, Ar-
H), 7.564 (1H, s, Ar-H), 12.513 (2H, s, Ar-H) 12.766 (1H, s, Ar-H) (S1 Fig) indicates the pres-
ence of a core evariquinone structure that was supported by a literature precedent (Fig 8)
[17,59]. Emerimidine A (2) was isolated as pale colorless amorphous powder. Its molecular
formula was deduced to be C10H12NO4 by m/z210.0559 [M+H]+(Fig 7).1H NMR chemical
shifts (DMSO d6, 400 MHz, δ ppm):3.772 (3H, s, OCH3), 3.796 (3H, s, OCH3), 4.147 (2H, s,
CH2), 6.989 (1H, s, Ar-H), 8.267 (1H, s, NH), 11.989 (1H,s, OH)(S1 Fig) indicates the presence
of a core emerimidine structure that was supported by a literature precedent (Fig 8) [60].The
purified metabolites significantly inhibited MRSA, S. aureus, L. monocytogenes, Pseudomonas
aeruginosa, Staphylococcus epidermidis and Candida albicans with MIC values of 3.15 to
Fig 6. (a, b) Thin layer chromatogram of ethyl acetate extract of E. variecolor CLB38 at 254 nm and 364 nm, respectively. (c) TLC-bioautography assay of
ethyl acetate extract showing zone of inhibition against Methicillin resistant Staphylococcus aureus. (d) TLC-bioautography assay of purified compound
evariquinone showing zone of inhibition against Candida albicans.
doi:10.1371/journal.pone.0172848.g006
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Fig 7. ESI-TOF-MS of (1) Evariquinone and (2) Emerimidine A showing major molecular ion peaks.
doi:10.1371/journal.pone.0172848.g007
Fig 8. Structure of (1) Evariquinone and (2) Emerimidine A.
doi:10.1371/journal.pone.0172848.g008
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12.5 μg/ml. MIC values of the purified compounds against test microorganisms are given in
Table 2 and Table 3.
ESI-TOF-MS analysis of compound 1 exhibited a molecular ion peak m/z 300.0458 corre-
sponding to the mass of evariquinone [17] whereas compound 2 exhibited a molecular ion
peak m/z 210.0559 corresponding to the mass of emerimidine A. Literature survey of TOF-MS
spectral data with that of emerimidine A indicates that, the metabolite could be a derivative of
isoindolones [56]. TOF-MS is a powerful tool for accurate and rapid identification of known
compounds, i.e. dereplication which has a great importance towards discovery of new antimi-
crobial agents [61–63]. This strategy enables to minimize wasting attempt on isolation of
known bioactive compounds. To our best knowledge, this work is the first report on systematic
analyses of endosymbiotic E. variecolor CLB38 to explore its antimicrobial potential via the
implication of PKS type I gene and chromatographic strategy to yield two polyketide antimi-
crobial metabolites. Development of these compounds as antimicrobial drugs after essential
evaluation like preclinical trials and toxicity may enlights new ideas to combat multidrug-resis-
tant pathogens.
Additionally, evariquinone is well known to possess anti-proliferative activity. It has been
reported from marine sponge derived Emericella variecolor [17] and endophytic Aspergillus
versicolor with a wide range of bioactivity [50]. Indeed, isoindolones derivatives also possess
biological activities. Specifically, a series of emerimidine (A-B) derived from endophytic fun-
gus Emericella sp. HK-ZJ which isolated from the inner bark of the mangrove plant Aegiceras
corniculatum (Myrsinaceae) has been reported to show anti-influenza A viral (H1N1) activity
[51]. Thus, from the present study, it suggests that the antimicrobial potential of these isolated
metabolites might play a significant role in symbiotic benefits of endosymbiont to the host.
Besides the discovery of natural products from the genus Emericella, the ability of E. variecolor
CLB38 to afford reported compounds which additionally support the evidence that, fungal
Table 2. Minimum inhibitory concentration (MIC in μg/ml) of purified compound Evariquinone from
endosymbiotic E. variecolor CLB38 against test microorganisms.
Test Pathogens Evariquinone (C10H11NO4)
Aspergillus fumigatus (MTCC 1811) 12.5
Bacillus subtilis (MTCC 121) 3.12
Candida albicans (MTCC 183) 3.12
Klebsiella pneumonia (MTCC 7407) 12.5
Methicillin resistant Staphylococcus aureus (ATCC 33915) 3.12
Pseudomonas aeruginosa (MTCC 7903) 12.5
Salmonella typhi (MTCC 733) 6.25
doi:10.1371/journal.pone.0172848.t002
Table 3. Minimum inhibitory concentration (MIC in μg/ml) of purified compound Emerimidine A from
endosymbiotic E. variecolor CLB38 against test microorganisms.
Test Pathogens Emerimidine A (C16H12O6)
Aspergillus fumigatus (MTCC 1811) 12.5
Bacillus subtilis (MTCC 121) 6.25
Candida albicans (MTCC 183) 6.25
Klebsiella pneumonia (MTCC 7407) 12.5
Methicillin resistant Staphylococcus aureus (ATCC 33915) 6.25
Pseudomonas aeruginosa (MTCC 7903) 12.5
Salmonella typhi (MTCC 733) 6.25
doi:10.1371/journal.pone.0172848.t003
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endosymbionts are entailed in the biosynthesis of antimicrobial agents. The chemical compo-
nents bear in this host might impact endosymbionts to produce potential antimicrobial com-
pounds. The need for future biological studies, like cytotoxicity, anti-malarial, antioxidant and
chemical profiling of secondary metabolites of E. variecolor CLB38 could be inspired towards
drug development. Clearly, formulation and development of new technologies are needed for
employing them in agricultural and pharmaceutical fields. Extensive exploration of various
nature antimicrobial compounds from endosymbiotic fungi associated with medicinal plants
of the Western Ghats might provide high insight to the evolution of mutualism and endo-
phyte-plant interactions. Therefore, the present study expands our knowledge of potential hid-
den endosymbiotic fungi from underexplored area are a promising source of novel
antimicrobial drugs.
Conclusion
This work demonstrates a holistic strategy for the rapid detection of antimicrobial polyketide
metabolites from endosymbiotic fungi. E. variecolor CLB38 is an anticipated source of antimi-
crobial polyketide agents which can be exploited in medical and industrial applications. PKS
type I gene is a functional gene of E. variecolor CLB38 which performs a significant role in fun-
gal endophytic secondary metabolite biosynthesis. Exploiting PKS biosynthetic genes to dis-
cover novel anti-infective agents are productive and fascinating in drug development area.
This work also highlights the importance of ITS2 RNA secondary structure modeling as a
potential molecular marker which helps to distinguish fungal endosymbionts with other path-
ogenic or free-living forms.
Supporting information
S1 Fig. (1) 1H NMR spectrum of Evariquinone, (2) 1H NMR spectrum of Emerimidine A.
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